Novo Holdings sees golden opportunity in dialysis company, contributes to USD 245m investment

Novo Holdings has coinvested alongside a group of current and new investors in Quantra Dialysis Technologies, who are injecting a total of USD 245m into the UK-based firm.

Photo: Novo Holdings / PR

It seemed as though Novo Holdings had ended the first half of 2021 with a bang, when it purchased diagnostics firm BBI Group last week, but the company has pulled out its checkbook again in a final flourish for the quarter.

Novo Holdings, which owns Novo Nordisk, is playing a central role in a series D funding round which has brought in USD 245m (DKK 1.5bn) to UK medtech company Quantra Dialysis Technologies.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs